Novo Nordisk says Health Canada has approved its weight loss drug Wegovy to reduce the risk of heart attacks in some adults. Kyle Benning has the details and more in Health Matters for Nov. 27, 2024.
Health Matters
Health Matters: Wegovy approved to reduce heart attack risk
More Videos
-
Health Matters: 4 people hospitalized after Pillsbury Pizza Pops recalled due to E. Coli concerns
-
Health Matters: Pillsbury brand Pizza Pops recalled due to E. coli concerns
-
Health Matters: New regulations targeting illegal drug chemicals, equipment
-
Health Matters: Eli Lilly says new oral pill helps maintain weight loss
-
Flu cases surge across Canada with H3N2 as the dominant strain of the virus
-
Health Matters: Flu season spiking ahead of holiday season, experts say
You are viewing an Accelerated Mobile Webpage.
View Original Article